新藥制劑委托研發(fā)
一站式CRO與CDMO服務(wù)
- 提供新藥毒理研究制劑、I~III期臨床樣品與商業(yè)化產(chǎn)品生產(chǎn)服務(wù)
- 美國FDA與中國NMPA雙認證的GMP設施與質(zhì)量系統
- 經(jīng)驗豐富的專(zhuān)業(yè)團隊,擅長(cháng)制定契合目標的產(chǎn)品開(kāi)發(fā)策略與解決難溶性藥物開(kāi)發(fā)難題
- 提供中美歐等國家地區的IND與NDA注冊資料撰寫(xiě)服務(wù)
- 國際接軌的設備儀器與嚴格的數據完整性體系,共同保障質(zhì)量合規
- 具備常規及高活性口服固體生產(chǎn)線(xiàn)
“One-Stop” Drug Product Development CRO and CDMO Service
- Manufacture of Tox, Phase I-III Clinical Samples and Commercial Supply
- US FDA and NMPA Compliant Quality System and GMP Facilities
- Experienced Professional Team, Specialized in Fit-for-Purposed and/or Problem-Solving Formulation for Poorly Soluble Compounds
- INDs and NDA Documents & Dossier Preparation for China, US and Europe Regulatory Agencies
- State-of-Art Equipment and Instruments, Excellent Data Integrity System to Ensure Quality and Compliance Outcome
Separated Oral Dosage Production Line for Regular and High Potency Drug